Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Psychosocial outcomes of repeated treatment of seizure clusters with midazolam nasal spray: Results of a phase 3, open-label extension trial.
Journal: Epilepsy & behavior : E&B
Published: September 01, 2022
Safety and efficacy of midazolam nasal spray in the outpatient treatment of patients with seizure clusters-a randomized, double-blind, placebo-controlled trial.
Journal: Epilepsia
Published: April 02, 2019
Safety and efficacy of midazolam nasal spray in the outpatient treatment of patients with seizure clusters: An open-label extension trial.
Journal: Epilepsia
Published: April 02, 2019
Three phase III randomized controlled trials of topical resiquimod 0.01-percent gel to reduce anogenital herpes recurrences.
Journal: Antimicrobial agents and chemotherapy
Published: April 09, 2014
Topical TLR7 agonist imiquimod can induce immune-mediated rejection of skin metastases in patients with breast cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 07, 2012
Showing 1-6 of 6
Last Updated: 09/26/2026